SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Jean-Jacques Rousseau Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJean-Jacques Rousseau
Date of birth1712-06-28
IdentifiersMRN HR-EN003-SYN-TD; SSN (made up) 000-03-2716
Document date2026-11-01
AuthorCelestine Marchetti-Owusu, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Primary care visit for beliefs of being plotted against, poor sleep, and difficulty passing urine. Concerns: Cannot pass urine freely: a thin stream, straining, burning, and the feeling of never emptying; fears the passage will one day close completely; dilates himself with urethral sounds every few days; Sleeps four hours a night and lies awake going over what his former friends are doing to his name; Wants to be believed and not called mad, to read his own records, and to decide for himself; has little trust in doctors. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for pain, no more than 3000 mg a dayTwo tablets up to every 8 hours as neededOral route1767-03-24activeS
Aripiprazole 5 mg oral tablet, one tablet by mouth each morningOne tablet each morningOral route1767-04-21activeS
Ibuprofen 400 mg oral tablet, one tablet by mouth three times a day with food for up to seven daysOne tablet three times a day with foodOral route1767-06-09 to 1767-06-16completedS

Procedures

ProcedureDatesStatusEvidence
Kidney, ureter, and bladder ultrasound: normal kidneys without hydronephrosis; bladder wall thickened to 6 mm with trabeculation; post-void residual 190 mL; prostate 24 mL1767-01-23 to 1767-01-23completedS
Retrograde urethrogram: a 1.5 cm ring-like narrowing of the proximal bulbar urethra with a lumen of about 8 French; penile urethra normal; no false passage or diverticulum1767-01-29 to 1767-01-29completedS
Voiding cystourethrogram: the bladder neck opens normally; the posterior urethra is dilated above the bulbar narrowing; no reflux; bladder trabeculation1767-01-29 to 1767-01-29completedS
Flexible cystourethroscopy: meatus normal in position and size (no hypospadias); a pale, dense ring of scar in the proximal bulbar urethra that the 16 French scope could not pass; no tumor or stone seen below it1767-01-29 to 1767-01-29completedS
Bulbar urethroplasty by excision and primary anastomosis, his informed choice: 1.5 cm of dense spongiofibrosis excised and the ends joined; 16 French urethral catheter left in place. Pathology: dense fibrosis of the corpus spongiosum without inflammation or malignancy1767-03-24 to 1767-03-24completedS
Pericatheter retrograde urethrogram three weeks after urethroplasty: no leak at the anastomosis; catheter removed and he voided well1767-04-14 to 1767-04-14completedS

Immunizations

DateVaccineStatusEvidence
1760-04-08Tdap vaccinecompletedS
1767-09-22Influenza vaccine, 1767-1768 seasoncompletedS
1767-09-22Recombinant zoster vaccine, dose 1 of 2completedS
1767-09-22Pneumococcal conjugate vaccine PCV20completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
Early childhoodAlmost continual retention of urine in early childhood, which he attributed to a defect in the bladderD (CLM-0003)
From 1748Urinary retention reported in his letters, and years of self-treatment with urethral bougiesD (CLM-0005, CLM-0004)
1758Frequent retentions with a rupture (hernia), and a year of languorD (CLM-0007)
1761A probe broke in the urethra; he feared for his lifeD (CLM-0005)
1766 to 1767Beliefs that the man who arranged his stay in England was plotting against him, and that the servants were spying on himD (CLM-0011)

Family History

RelativeConditionAge at deathEvidence
motherDied nine days after his birth; cause not recorded in the cited sourceD (CLM-0002)

Health Concerns

ConcernStatusEvidence
Cannot pass urine freely: a thin stream, straining, burning, and the feeling of never emptying; fears the passage will one day close completely; dilates himself with urethral sounds every few daysactiveS
Sleeps four hours a night and lies awake going over what his former friends are doing to his nameactiveS
Wants to be believed and not called mad, to read his own records, and to decide for himself; has little trust in doctorsactiveS

Assessment

Most recent measures: Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 1767-07-14; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 9 on 1767-01-20; Total score [MoCA] 28 on 1767-01-20; Total score [AUDIT-C] 1 on 1767-09-22; Symptom score [AUASI] 5 on 1767-07-14; If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS] 1 on 1767-07-14; Maximum Urine flow by Uroflowmetry 20.8 on 1767-07-14; US Urinary bladder Volume post void 20 on 1767-06-09; Leukocytes [#/area] in Urine sediment by Microscopy high power field 2 on 1767-03-10; Sodium [Moles/volume] in Serum or Plasma 140 on 1767-01-20; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1767-03-10; Carbon dioxide, total [Moles/volume] in Serum or Plasma 25 on 1767-01-20; Urea nitrogen [Mass/volume] in Serum or Plasma 17 on 1767-01-20; Creatinine [Mass/volume] in Serum or Plasma 0.99 on 1767-07-14; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1762)/1.73 sq M 91 on 1767-07-14; Glucose [Mass/volume] in Serum or Plasma 94 on 1767-07-14; Calcium [Mass/volume] in Serum or Plasma 9.4 on 1767-01-20; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 on 1767-01-20; Hemoglobin [Mass/volume] in Blood 14.4 on 1767-03-10; Leukocytes [#/volume] in Blood by Automated count 6.2 on 1767-01-20; Platelets [#/volume] in Blood by Automated count 238 on 1767-01-20; Thyrotropin [Units/volume] in Serum or Plasma 2.1 on 1767-01-20; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 410 on 1767-01-20; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 1767-07-14; Cholesterol [Mass/volume] in Serum or Plasma 201 on 1767-07-14; Cholesterol in HDL [Mass/volume] in Serum or Plasma 47 on 1767-07-14; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 126 on 1767-07-14; Triglyceride [Mass/volume] in Serum or Plasma 138 on 1767-07-14; Waist Circumference at umbilicus by Tape measure 93 on 1767-07-14; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1767-09-22 [S]

Strengths and supports: Supports: his long-term partner at home, his writing, and his daily walks among plants; two old correspondents he still trusts [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Fixed beliefs that former friends and colleagues are plotting to ruin him, with poor sleep, present for years and worse over the past year; cause not yet established; psychiatric and medical assessment under wayresolvedconfirmed R46.5S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the psychiatry consultation; his documented beliefs of 1766 are echoed.
Weak urinary stream, straining, incomplete emptying (post-void residual 180 mL), and painful urination since childhood, treated for years by self-dilation with urethral sounds; cause not yet established; urethral imaging and endoscopy bookedresolvedconfirmed R33.9S — Synthetic presenting concern at the index visit, superseded by the urethrogram and cystoscopy diagnosis; his documented lifelong retention and self-treatment with bougies are echoed.
Delusional disorder, persecutory type (DSM-5-TR), of about nine years' duration, with non-bizarre beliefs of a coordinated campaign against him; no hallucinations, disorganization, or mood episode; normal cognition; insomnia secondary to preoccupation; synthetic modern counterpart of his documented persecutory beliefsactiveconfirmed F22S — Synthetic modern diagnosis. His beliefs and conduct are documented (D); calling them a paranoid delusion is a retrospective interpretation (R), made difficult by the real persecution he suffered.
Bulbar urethral stricture, 1.5 cm, dense and ring-like (lumen about 8 French), idiopathic and probably congenital in origin, with decades of self-dilation; bladder trabeculation without hydronephrosis; kidney function normal; synthetic modern counterpart of his documented lifelong urinary retentionactiveconfirmed N35.812S — Synthetic modern diagnosis. His lifelong retention is documented (D); its cause is disputed (R), and the autopsy found no urethral lesion (D), so this stricture is not presented as his historical diagnosis.
Right inguinal hernia, reducible and minimally symptomatic, likely aggravated by years of straining to pass urineactiveconfirmed K40.90S — Synthetic finding on examination; it echoes the documented rupture of 1758, whose site the source does not state.
Acute low back strain after splitting firewood, without sciatica, red flags, or urinary retention (bladder scan 20 mL); resolved within three weeksresolvedconfirmed S39.012AS — Synthetic common injury; the wood-splitting echoes a documented habit (CLM-0020), but no back injury is documented.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1767-01-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
1767-01-20Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]9{score}S
1767-01-20Total score [MoCA]28{score}S
1767-01-20Total score [AUDIT-C]1{score}S
1767-01-20Symptom score [AUASI]24{score}S
1767-01-20If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS]5{score}S
1767-01-20Maximum Urine flow by Uroflowmetry6.2mL/sA maximum flow of 15 mL/s or more is normal for a voided volume above 150 mLLowS
1767-01-20US Urinary bladder Volume post void180mL<=100 mLHighS
1767-01-20Leukocytes [#/area] in Urine sediment by Microscopy high power field3/[HPF]<=5 /[HPF]NormalS
1767-01-20Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
1767-01-20Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
1767-01-20Carbon dioxide, total [Moles/volume] in Serum or Plasma25mmol/L22-29 mmol/LNormalS
1767-01-20Urea nitrogen [Mass/volume] in Serum or Plasma17mg/dL8-23 mg/dLNormalS
1767-01-20Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
1767-01-20Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1762)/1.73 sq M87mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1767-01-20Glucose [Mass/volume] in Serum or Plasma93mg/dL70-99 mg/dLNormalS
1767-01-20Calcium [Mass/volume] in Serum or Plasma9.4mg/dL8.6-10.3 mg/dLNormalS
1767-01-20Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L<=41 U/LNormalS
1767-01-20Hemoglobin [Mass/volume] in Blood14.6g/dL13.2-16.6 g/dLNormalS
1767-01-20Leukocytes [#/volume] in Blood by Automated count6.210*3/uL3.4-9.6 10*3/uLNormalS
1767-01-20Platelets [#/volume] in Blood by Automated count23810*3/uL135-317 10*3/uLNormalS
1767-01-20Thyrotropin [Units/volume] in Serum or Plasma2.1m[IU]/L0.4-4 mIU/LNormalS
1767-01-20Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma410pg/mL232-1245 pg/mLNormalS
1767-03-10Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S
1767-03-10Symptom score [AUASI]22{score}S
1767-03-10US Urinary bladder Volume post void210mL<=100 mLHighS
1767-03-10Leukocytes [#/area] in Urine sediment by Microscopy high power field2/[HPF]<=5 /[HPF]NormalS
1767-03-10Creatinine [Mass/volume] in Serum or Plasma1.04mg/dL0.74-1.35 mg/dLNormalS
1767-03-10Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1762)/1.73 sq M85mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1767-03-10Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
1767-03-10Hemoglobin [Mass/volume] in Blood14.4g/dL13.2-16.6 g/dLNormalS
1767-04-21Symptom score [AUASI]6{score}S
1767-04-21If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS]2{score}S
1767-04-21Maximum Urine flow by Uroflowmetry21.5mL/sA maximum flow of 15 mL/s or more is normal for a voided volume above 150 mLNormalS
1767-04-21US Urinary bladder Volume post void25mL<=100 mLNormalS
1767-04-21Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
1767-04-21Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.74-1.35 mg/dLNormalS
1767-04-21Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1762)/1.73 sq M92mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1767-04-21Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
1767-04-21Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS
1767-04-21Cholesterol [Mass/volume] in Serum or Plasma196mg/dL<=199 mg/dLNormalS
1767-04-21Cholesterol in HDL [Mass/volume] in Serum or Plasma48mg/dL>=40 mg/dLNormalS
1767-04-21Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation122mg/dL<=129 mg/dLNormalS
1767-04-21Triglyceride [Mass/volume] in Serum or Plasma130mg/dL<=149 mg/dLNormalS
1767-04-21Waist Circumference at umbilicus by Tape measure92cmBelow 102 cm for menNormalS
1767-07-14Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
1767-07-14Symptom score [AUASI]5{score}S
1767-07-14If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS]1{score}S
1767-07-14Maximum Urine flow by Uroflowmetry20.8mL/sA maximum flow of 15 mL/s or more is normal for a voided volume above 150 mLNormalS
1767-07-14US Urinary bladder Volume post void30mL<=100 mLNormalS
1767-07-14Creatinine [Mass/volume] in Serum or Plasma0.99mg/dL0.74-1.35 mg/dLNormalS
1767-07-14Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1762)/1.73 sq M91mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1767-07-14Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
1767-07-14Hemoglobin A1c/Hemoglobin.total in Blood5.5%<=5.6%NormalS
1767-07-14Cholesterol [Mass/volume] in Serum or Plasma201mg/dL<=199 mg/dLHighS
1767-07-14Cholesterol in HDL [Mass/volume] in Serum or Plasma47mg/dL>=40 mg/dLNormalS
1767-07-14Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation126mg/dL<=129 mg/dLNormalS
1767-07-14Triglyceride [Mass/volume] in Serum or Plasma138mg/dL<=149 mg/dLNormalS
1767-07-14Waist Circumference at umbilicus by Tape measure93cmBelow 102 cm for menNormalS
1767-06-09US Urinary bladder Volume post void20mL<=100 mLNormalS
1767-09-22Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1767-09-22Total score [AUDIT-C]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
1767-01-20Body height166cmS
1767-01-20Body weight63.8kgS
1767-01-20Body mass index (BMI) [Ratio]23.2kg/m2S
1767-01-20Systolic blood pressure132mm[Hg]S
1767-01-20Diastolic blood pressure82mm[Hg]S
1767-01-20Heart rate84/minS
1767-01-20Respiratory rate16/minS
1767-01-20Body temperature36.7CelS
1767-01-20Oxygen saturation in Arterial blood by Pulse oximetry98%S
1767-02-03Body height166cmS
1767-02-03Body weight63.6kgS
1767-02-03Body mass index (BMI) [Ratio]23.1kg/m2S
1767-02-03Systolic blood pressure128mm[Hg]S
1767-02-03Diastolic blood pressure80mm[Hg]S
1767-02-03Heart rate80/minS
1767-02-03Respiratory rate14/minS
1767-02-03Body temperature36.6CelS
1767-02-03Oxygen saturation in Arterial blood by Pulse oximetry98%S
1767-03-10Body height166cmS
1767-03-10Body weight64kgS
1767-03-10Body mass index (BMI) [Ratio]23.2kg/m2S
1767-03-10Systolic blood pressure126mm[Hg]S
1767-03-10Diastolic blood pressure80mm[Hg]S
1767-03-10Heart rate78/minS
1767-03-10Respiratory rate14/minS
1767-03-10Body temperature36.6CelS
1767-03-10Oxygen saturation in Arterial blood by Pulse oximetry98%S
1767-04-21Body height166cmS
1767-04-21Body weight63.2kgS
1767-04-21Body mass index (BMI) [Ratio]22.9kg/m2S
1767-04-21Systolic blood pressure124mm[Hg]S
1767-04-21Diastolic blood pressure78mm[Hg]S
1767-04-21Heart rate74/minS
1767-04-21Respiratory rate14/minS
1767-04-21Body temperature36.7CelS
1767-04-21Oxygen saturation in Arterial blood by Pulse oximetry99%S
1767-07-14Body height166cmS
1767-07-14Body weight64.4kgS
1767-07-14Body mass index (BMI) [Ratio]23.4kg/m2S
1767-07-14Systolic blood pressure124mm[Hg]S
1767-07-14Diastolic blood pressure78mm[Hg]S
1767-07-14Heart rate72/minS
1767-07-14Respiratory rate14/minS
1767-07-14Body temperature36.6CelS
1767-07-14Oxygen saturation in Arterial blood by Pulse oximetry99%S
1767-06-09Body height166cmS
1767-06-09Body weight64kgS
1767-06-09Body mass index (BMI) [Ratio]23.2kg/m2S
1767-06-09Systolic blood pressure134mm[Hg]S
1767-06-09Diastolic blood pressure84mm[Hg]S
1767-06-09Heart rate86/minS
1767-06-09Respiratory rate16/minS
1767-06-09Body temperature36.7CelS
1767-06-09Oxygen saturation in Arterial blood by Pulse oximetry98%S
1767-09-22Body height166cmS
1767-09-22Body weight64.6kgS
1767-09-22Body mass index (BMI) [Ratio]23.4kg/m2S
1767-09-22Systolic blood pressure122mm[Hg]S
1767-09-22Diastolic blood pressure78mm[Hg]S
1767-09-22Heart rate70/minS
1767-09-22Respiratory rate14/minS
1767-09-22Body temperature36.6CelS
1767-09-22Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
1767-01-20Primary care visit for beliefs of being plotted against, poor sleep, and difficulty passing urinefinishedS
1767-02-03Psychiatry consultation and review of the urethral imaging and cystoscopyfinishedS
1767-03-10Seven-week review of psychotherapy and safety, and preparation for urethroplastyfinishedS
1767-04-21Review four weeks after urethroplasty; start of aripiprazolefinishedS
1767-07-14Twelve-week aripiprazole and urethroplasty follow-upfinishedS
1767-06-09Same-day sick visit for low back painfinishedS
1767-09-22Adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Engagement without confrontation: listen to his account in full, acknowledge his distress and the real conflicts in his life, neither argue with nor agree with the beliefs, and agree shared goals that matter to him (sleep, less distress, freedom to write, and his bladder); give him copies of his results and notescompletedGL-APA-SCZ-2020, GL-DSM5TR-2022S
Look for medical, substance, and neurocognitive causes: neurological examination, MoCA, blood count, metabolic panel, calcium, TSH, and vitamin B12; review of medicines and alcohol; brain imaging only if the course or examination is atypicalcompletedGL-APA-SCZ-2020, GL-DSM5TR-2022S
Psychiatry consultation to confirm the diagnosis and the differential, assess the risk of harm to himself and others, advise on an antipsychotic and on cognitive behavioral therapy for psychosis, and assess his capacity to consent to urethral surgerycompletedGL-APA-SCZ-2020, GL-DSM5TR-2022S
Structured suicide and violence risk assessment with a written safety plan and the 988 Suicide & Crisis Lifeline; no firearms in the home; risk reviewed at every visit; signs for urgent care written down with himcompletedGL-SUICIDE-2024S
Urology assessment: IPSS, uroflowmetry, bladder scan for post-void residual, urinalysis, and creatinine now, and kidney and bladder ultrasound this week; retrograde urethrogram, voiding cystourethrogram, and flexible cystoscopy by the urology team next week; stop self-dilation with urethral sounds (urethral rest) and come in the same day if he cannot pass urinecompletedGL-AUA-USD-2023S
Right inguinal hernia: watchful waiting while it is minimally symptomatic, with the warning signs of incarceration explained; reassess once the straining has been relievedcompletedGL-HERNIA-2018S
Sleep: fixed rising time, daylight walks, no writing about his enemies after 8 pm, and no sedating antihistamines or anticholinergic sleep aids, which can worsen urinary retentioncompletedGL-APA-SCZ-2020, GL-DSM5TR-2022S
Cognitive behavioral therapy for psychosis with the clinic psychologist, about 16 weekly to fortnightly sessions, aimed at distress, worry, sleep, and checking and safety behaviors rather than at disproving the beliefscompletedGL-APA-SCZ-2020, GL-DSM5TR-2022S
Antipsychotic offered by shared decision-making: aripiprazole 5 mg daily recommended, for its low anticholinergic, sedative, and metabolic effects; he declined it at the consultation and the offer stays open; no compulsory treatment while he remains safecompletedGL-APA-SCZ-2020, GL-DSM5TR-2022S
Bulbar urethroplasty by excision and primary anastomosis, his choice after dilation, internal urethrotomy, and self-catheterization had been explained; urethral rest until surgery; capacity to consent confirmed; catheter for three weeks with a pericatheter urethrogram before removal; acetaminophen rather than opioids afterwardscompletedGL-AUA-USD-2023S
Aripiprazole 5 mg each morning, started at his request; weight at 4, 8, and 12 weeks then quarterly; blood pressure, fasting glucose or hemoglobin A1c, and lipids at baseline and 12 weeks then yearly; waist at baseline and yearly; akathisia check at each visit; AIMS at baseline and every 6 monthscompletedGL-CMID-2026, GL-APA-SCZ-2020S
Surveillance after urethroplasty: symptoms and IPSS, uroflowmetry, and post-void residual at about 3, 6, and 12 months; urethroscopy or a urethrogram only if symptoms return or the flow fallscompletedGL-AUA-USD-2023S

Goals

GoalTargetStatusOutcomeProvenance
Sleep at least six hours most nights1767-07-14completedAbout six and a half hours most nights by twelve weeks on aripiprazoleS
Less distress and preoccupation from the beliefs, so that he can write each morning and walk without fear1767-07-14completedPreoccupation down from most of the day to under an hour; writing most mornings; the beliefs persist with less convictionS
Stay in care: keep visits and psychotherapy sessions, with no sudden break in treatment1767-12-15activeKept every visit and fourteen of sixteen CBT sessionsS
Pass urine with a free stream without self-dilation: maximum flow above 15 mL/s and post-void residual below 100 mL within three months of surgery1767-07-14completedMaximum flow 20.8 mL/s and residual 30 mL four months after urethroplasty; no sounds used since JanuaryS
No harm to himself or anyone else; safety plan kept current1767-12-15activeNo suicidal or violent thoughts at any visit; safety plan reviewed at each visitS

Functional Status

Mental Status

Structured synthetic safety assessment on 1767-01-20: current ideation absent, intent absent, plan absent. Outpatient care with a two-week follow-up. He has persecutory beliefs but no thoughts of suicide or of harming anyone, no plan to confront or act against the people he fears, no command hallucinations, and no access to firearms, so he does not need hospital care. Risk factors reviewed: a persecutory delusion, insomnia, social isolation, chronic pain on passing urine, male sex, and a past thought of suicide after a painful accident many years ago. Signs for urgent care were written down with him (thoughts of harming himself or anyone else, planning to confront someone, not sleeping at all for two nights, or a sudden urge to leave his home). A written safety plan was made with him, and the 988 Suicide & Crisis Lifeline (call or text 988) was saved in his phone. Safety is reviewed at every visit [S]